Ride to Conquer - Homepage

Dollars at Work


Jewish General Hospital

Since 2009, the Enbridge Ride to Conquer Cancer has raised over $37 million and is currently Quebec’s largest cycling fundraiser.

Funds raised through The Enbridge Ride to Conquer Cancer support vital cancer research, treatment, care and prevention programs at the Jewish General Hospital’s Segal Cancer Centre and other partners across Quebec.

Jewish General Hospital’s Segal Cancer Centre is a leader in Quebec in implementing a focused and comprehensive approach to fighting cancer through a combination of medical treatment, patient care, family support and scientific research. The centre is one of few in the world which offers a combination of strong research and highly skilled clinicians under one roof.

Their world-leading doctors, researchers and scientists at Jewish General Hospital are working to develop new technologies in the areas of molecular diagnostics, functional imaging, biomarkers, molecular target discovery and validation, and advanced targeted radiation therapy.

Funds raised through The Ride are put to use immediately to attract and retain world-leading doctors, scientists and researchers to implement the most promising cancer research programs and treatments including:

  • Dr. Nathalie Johnson: Having recently returned to Montreal from her five-year research training at the British Columbia Cancer Agency in Vancouver, Dr. Johnson's research focuses on determining the genetic abnormalities that are associated with a poor response to chemotherapy in lymphoma, especially in adolescent and young adult patients.
  • Dr. Ivan Topisirovic: Dr. Topisirovic, who studies changes in mRNA metabolism and protein synthesis in cancer, has been appointed an Investigator at the JGH Lady Davis Institute for Medical Research (LDI) and an Assistant Professor in McGill University’s Department of Oncology.
  • Dr. Frank Bladou: Dr. Bladou, a uro-oncologist, has been nominated Chief of Urology, as well as team leader of the Urologic Oncology Department at the JGH and is also a Professor at McGill University.
  • Dr. Michael Witcher: Dr. Witcher is a new investigator who is studying the fundamental aspects of gene regulation. This research could lead to new approaches in cancer treatments.

Funds raised through The Ride also power other core cancer areas at Jewish General Hospital including:

  • The Centre of Clinical Research and Evaluative Oncology (CCREO) - With a staff of more than 50 oncologists, researchers and associates, who work closely with a team of researchers from the UHCG Cancer Research Department to develop and enhance research programs in the fields of oncology, X-ray and genomics at the CHU de Quebec.
  • The acquisition of high-tech machines and equipment and the enhancements of treatments via the “Fondation régionale pour la santé de Trois-Rivières (RSTR)”. The optimization of care allows patients to benefit from more accurate diagnosis and to receive more specialized treatments within the community, eliminating the need to commute to larger centres and benefit from the support of their friends and family.